Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28473238 | 1.00 | LMNA (0.44) | LMNACYP2C9CYP19A1 | |
| SCHEMBL22877663 | 1.00 | LMNA (0.44) | LMNACYP2C9CYP19A1 | |
| SCHEMBL18268930 | 0.78 | LMNA (0.38) | LMNACYP2C9 | |
| SCHEMBL9881074 | 0.78 | LMNA (0.38) | LMNACYP2C9 | |
| SCHEMBL18022218 | 0.78 | — | — | |
| SCHEMBL22877664 | 0.68 | ALDH1A1 (0.32) | LMNACYP2C9 | |
| SCHEMBL22877401 | 0.68 | ALDH1A1 (0.32) | LMNACYP2C9 | |
| SCHEMBL22877666 | 0.68 | ALDH1A1 (0.32) | LMNACYP2C9 | |
| SCHEMBL3163693 | 0.68 | LMNA (0.34) | LMNACYP2C9 | |
| SCHEMBL10385896 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11312804-B2 | Polymerizable compound, polymerizable composition, polymer, and photoresist composition | JNC CORPORATION (JP) | 2022-04-26 | — | — | US | disclosed |
| US-20210009546-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND PHOTORESIST COMPOSITION | JNC CORPORATION (JP) | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210009546-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND PHOTORESIST COMPOSITION | PAH, RER1, P4HA1 | LMNA 3846/4885CYP2C9 1614/4885CYP19A1 421/4885 |
| US-11312804-B2 | Polymerizable compound, polymerizable composition, polymer, and photoresist composition | PAH, RER1, P4HA1 | LMNA 3846/4885CYP2C9 1614/4885CYP19A1 421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.